dianax miniaturized microfluidics-based lab-on-a-chip will bring laboratory testing to the patient’s fingertips including HbA1c and CRP. According to Data Bridge Market Research, the Europe Point-of-Care Testing (POCT) devices market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The major factors driving the growth of this market are the increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, HBA1C, CRP… More info at http://databridgemarketresearch.com/news/product-launch/europe-poct-device-market/